Try our beta test site
3 studies found for:    AMG-145 20110118
Show Display Options
Rank Status Study
1 Not yet recruiting A Open-label Extension Study to Assess Long-term Safety of Evolocumab in Subjects Who Completed Fourier (20110118)
Condition: Dyslipidemia
Intervention: Drug: Evolocumab
2 Completed Evaluating PCSK9 Binding antiBody Influence oN coGnitive HeAlth in High cardiovascUlar Risk Subjects
Condition: Dyslipidemia
Interventions: Biological: Evolocumab (AMG 145);   Other: Placebo;   Drug: Effective statin therapy
3 Completed Further Cardiovascular Outcomes Research With PCSK9 Inhibition in Subjects With Elevated Risk
Condition: Dyslipidemia
Interventions: Biological: Evolocumab (AMG 145);   Other: Placebo;   Drug: Effective statin therapy

Study has passed its completion date and status has not been verified in more than two years.